Hemostatic Agents Market on Path to Hit $5.43 Billion by 2029 at 5.3% CAGR

Use ONLINE30 for 30% savings on global market reports and stay on top of tariff updates, market trends, and economic shifts worldwide.

Hemostatic Agents Market Outlook: What Size And CAGR Are Anticipated By 2025?
In recent times, the market size for hemostatic agents has seen significant growth. Predictions state that it is set to increase from $4.19 billion in 2024 to $4.42 billion in 2025, experiencing a compound annual growth rate (CAGR) of 5.5%. This previous growth trend can be linked to factors such as global population aging, the escalation in trauma and accident instances, a heightened prevalence of cardiovascular disorders, an increase in bleeding disorders like hemophilia, and a surge in the number of patients suffering from liver diseases and coagulation issues.

What Is the Expected CAGR for the Hemostatic Agents Market Growth Through 2029?
In the coming years, the market for hemostatic agents is predicted to experience significant growth. It is projected to expand to $5.43 billion in 2029, with a compound annual growth rate (CAGR) of 5.3%. The escalation during the forecast period can be credited to the rising number of surgical procedures, enhancements in minimally invasive surgeries, increased demand for orthopedic surgeries, the expansion of cosmetic and aesthetic surgeries, and the amplified requirement for hemostasis in dental surgeries. The forecast period is poised to witness key trends such as improvements in hemostatic agent formulations, the debut of bioengineered and recombinant agents, superior product shelf-life and stability, creation of combination products, and the fabrication of synthetic and absorbable hemostats.

Explore The Complete Report Now:
https://www.thebusinessresearchcompany.com/report/hemostatic-agents-global-market-report

What Are the Primary Drivers Behind Hemostatic Agents Market Growth?
The hemostatic agents market is predicted to expand due to a rise in the number of surgical procedures. These procedures, which are operations carried out by healthcare professionals to modify, repair or remove body parts for health reasons, are primarily increasing because of a surge in chronic illnesses. These conditions often necessitate surgeries as a way to control health complications and enhance patient's health outcomes. Hemostatic agents play a crucial role in these surgeries, aiding in rapid blood staunching, minimizing blood loss, and enhancing the clarity of the operational site for precise work. The British Association of Aesthetic Plastic Surgeons (BAAPS) disclosed in March 2023 that in 2022, the number of cosmetic procedures carried out totaled 31,057, representing a 102% increase from the previous year. Women accounted for 93% of these procedures, showing a 101% increase relative to 2021. Consequently, the current upswing in surgical procedures is fueling the hemostatic agents market's growth.

Get Free Sample Report Here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=25780&type=smp

What Are the Key Segments Driving Hemostatic Agents Market Growth?
The hemostatic agents market covered in this report is segmented -

1) By Type: Thrombin-Based Hemostats, Gelatin-Based Hemostats, Collagen-Based Hemostats, Oxidized Regenerated Cellulose-Based Hemostats, Combination Hemostats, Fibrin Sealants, Other Types
2) By Application: Trauma, Cardiovascular Surgery, General Surgery, Plastic Surgery, Orthopedic Surgery, Neurosurgery, Other Applications
3) By End-User: Hospitals, Surgery Centers, Nursing Homes, Other End Users

Subsegments:
1) By Thrombin-Based Hemostats: Bovine Thrombin, Human Thrombin, Poxidized Regenerated Cellulose (Orc)Ine Thrombin, Combined Thrombin Products
2) By Gelatin-Based Hemostats: Absorbable Gelatin Sponges, Gelatin Powder, Gelatin Paste, Gelatin With Thrombin
3) By Collagen-Based Hemostats: Collagen Sponges, Collagen Powder, Collagen With Thrombin, Collagen Sheets Or Patches
4) By Oxidized Regenerated Cellulose-Based Hemostats: Oxidized Regenerated Cellulose (ORC) Pads, Oxidized Regenerated Cellulose (ORC) Mesh, Oxidized Regenerated Cellulose (ORC) Powder, Oxidized Regenerated Cellulose (ORC) With Other Active Agents
5) By Combination Hemostats: Gelatin And Thrombin Combinations, Collagen And Thrombin Combinations, Oxidized Regenerated Cellulose (ORC) And Thrombin Combinations, Multi-Agent Combinations
6) By Fibrin Sealants: Human Plasma-Derived Fibrin Sealants, Recombinant Fibrin Sealants, Sprayable Fibrin Sealants, Liquid Fibrin Sealants, Fibrin Sealants With Antimicrobials
7) By Other Types: Polysaccharide-Based Hemostats, Synthetic Polymer-Based Hemostats, Microfibrillar Collagen Hemostats, Chitosan-Based Hemostats, Calcium-Based Hemostats

What Are the Technological Trends Impacting the Hemostatic Agents Market?
Key players in the hemostatic agents market are concentrating their efforts on creating innovative solutions such as collagen-based hemostats, aiming to deliver swift and efficient hemostasis and tissue sealing for both conventional and less invasive surgeries. Collagen-based hemostats, created from purified collagen, aid in curbing bleeding by augmenting the body's indigenous clotting mechanism at a wound or surgical cut site. For example, in March 2025, US-based healthcare firm Baxter introduced HEMOPATCH Sealing Hemostat, an absorbable collagen-based pad. The advanced pad integrates a dual-action system that merges a collagen matrix with an NHS-PEG layer that transforms into a hydrogel upon making contact with moisture, thus swiftly sealing bleeding areas. The adhesion of the patch to damp tissues is robust, making it appropriate for both traditional and low invasive surgeries where other agents might prove to be less effective. The pad facilitates hemostasis in under two minutes, eliminating the necessity for temperature-managed storage or specific preparation, thus simplifying surgical operations. Additionally, it naturally dissolves in the body within a span of 6 to 8 weeks and can be stored at ambient temperature for up to three years, efficiently addressing significant clinical and storage needs.

Customize Your Insights And Get The Full Report Here:
https://www.thebusinessresearchcompany.com/customise?id=25780&type=smp

Who Are the Major Competitors in the Global Hemostatic Agents Market?
Major companies operating in the hemostatic agents market are Pfizer Inc., Johnson & Johnson Services Inc., Becton, Dickinson & Co., CSL Ltd., Baxter International Inc., Teleflex Inc., Integra LifeSciences Holdings Corp., Gelita Medical, Artivion Inc., B. Braun Melsungen AG, Advanced Medical Solutions Group Plc, Z‐Medica, Marine Polymer Technologies Inc., MedTrade Products Ltd., Samyang Holdings Corp., Vascular Solutions Pc, BioCer Entwicklungs GmbH, Starch Medical Inc., Arch Therapeutics Inc., Medcura Inc., Biom'Up SAS.

Which Region Dominates the Hemostatic Agents Market Share in 2025?
North America was the largest region in the hemostatic agents market in 2024. The regions covered in the hemostatic agents market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Saumya Sahey
Europe: +44 7882 955267,
Asia: +44 7882 955267 & +91 8897263534,
Americas: +1 310-496-7795
Email: saumyas@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.